The purpose of this contract is to support the advanced development and manufacture of a Modified Vaccinia Ankara (MVA) vaccine for smallpox.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
N01
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
243579
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
855
-
Ed Inst. Type
-
Funding ICs
NIAID:243579\
-
Funding Mechanism
Contracts, Extramural
-
Study Section
-
Study Section Name